Alcaftadine
- Generic Name
- Alcaftadine
- Brand Names
- Lastacaft
- Drug Type
- Small Molecule
- Chemical Formula
- C19H21N3O
- CAS Number
- 147084-10-4
- Unique Ingredient Identifier
- 7Z8O94ECSX
Overview
Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010.
Background
Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010.
Indication
用于2岁以上人群过敏性结膜炎相关性眼部瘙痒的治疗。
Associated Conditions
- Allergic Conjunctivitis (AC)
Clinical Trials
FDA Approved Products
LASTACAFT
Manufacturer:Physicians Total Care, Inc.
Route:OPHTHALMIC
Strength:2.5 mg in 1 mL
Approved: 2011/08/22
NDC:54868-6294
LASTACAFT
Manufacturer:Rebel Distributors Corp
Route:OPHTHALMIC
Strength:2.5 mg in 1 mL
Approved: 2010/09/30
NDC:42254-288
LASTACAFT
Manufacturer:Allergan, Inc.
Route:OPHTHALMIC
Strength:2.5 mg in 1 mL
Approved: 2023/11/03
NDC:0023-4290
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath